Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
Gene Biotherapeutics, Inc. (CRXM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/05/2021 8-K Changes in Registrant's Certifying Accountant
07/28/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "GENE BIOTHERAPEUTICS ANNOUNCES DIRECTOR RETIREMENT FOLLOWING 16 YEARS OF DISTINGUISHED SERVICE"
04/26/2021 8-K Quarterly results
05/28/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock",
"Preferred Stock Purchase Agreement for the purchase of Series B Convertible Preferred Stock",
"Reaffirmation and Ratification Agreement between Gene Biotherapeutics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd",
"Distribution and License Agreement between Angionetics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd",
"Amendment No. 1 to Distribution and License Agreement between Angionetics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd",
"License and Patent Assignment Agreement between Activation Therapeutics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd",
"GENE BIOTHERAPEUTICS SECURES INVESTMENT FROM NOSTRUM PHARMACEUTICALS, LLC"
03/20/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "GENE BIOTHERAPEUTICS ANNOUNCES DIRECTOR RETIREMENT FOLLOWING A DECADE OF DISTINGUISHED SERVICE"
09/13/2018 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "GENE BIOTHERAPEUTICS ANNOUNCES SALE OF EXCELLAGEN TECHNOLOGY PLATFORM; RETAINS COMMERCIALIZATION RIGHTS FOR GREATER CHINA AND RUSSIAN FEDERATION",
"Angionetics Generx Investor Presentations"
01/09/2018 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "TAXUS CARDIUM ANNOUNCES NAME CHANGE TO GENE BIOTHERAPEUTICS"
01/10/2017 8-K Quarterly results
01/05/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "RECENT PRESS COVERAGE SCIENTIFIC AMERICAN"
01/04/2017 8-K Form 8-K - Current report
12/14/2016 8-K Form 8-K - Current report
10/03/2016 8-K Entry into a Material Definitive Agreement
09/27/2016 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Exchange and Redemption Agreement between the registrant and Sabby Healthcare Volatility Master Fund, Ltd"
09/13/2016 8-K Form 8-K - Current report
07/11/2016 8-K Form 8-K - Current report
07/11/2016 8-K Form 8-K - Current report
07/22/2015 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Exchange and Redemption Agreement between the registrant and Sabby Healthcare Volatility Master Fund, Ltd"
06/26/2015 8-K Submission of Matters to a Vote of Security Holders, Other Events
04/13/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "ANGIONETICS INITIAL EQUITY FUNDING TO ADVANCE AS INDEPENDENT COMPANY TO DEVELOP AND COMMERCIALIZE PHASE 3 GENERX ® GENE THERAPY PRODUCT CANDIDATE"
04/09/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "TAXUS CARDIUM ANNOUNCES AGREEMENT WITH DR. REDDY'S LABORATORIES TO CO-DEVELOP, MARKET & SELL GENERX ANGIOGENIC MICROVASCULAR GENE THERAPY IN CERTAIN INTERNATIONAL MARKETS"
04/03/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/15/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "TAXUS CARDIUM ELECTS THREE NEW BOARD MEMBERS INCLUDING PRC STRATEGIC INVESTOR JIAYUE ZHANG, JOHN WALLACE U.S. EQUITY TRADING SERVICES EXECUTIVE AND WEI-WEI ZHANG INTERNATIONAL GENE THERAPY PIONEER"
06/30/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "CARDIUM ANNOUNCES POSITIVE INTERIM PHASE 3 CLINICAL DATA SHOWING SIGNIFICANT EFFICACY OF GENERX ® ANGIOGENIC GENE THERAPY FOR MYOCARDIAL ISCHEMIA DUE TO CORONARY ARTERY DISEASE AT THE 2014 BIO INTERNATIONAL CONVENTION"
06/10/2014 8-K Submission of Matters to a Vote of Security Holders, Other Events
03/18/2014 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Certificate of Ownership and Merger",
"CARDIUM BECOMES TAXUS CARDIUM PHARMACEUTICALS GROUP IN CONNECTION WITH STRATEGIC COLLABORATION AND FUNDING WITH SHANXI TAXUS PHARMACEUTICALS"
03/03/2014 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Strategic Collaboration Agreement between Cardium Therapeutics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd.",
"Securities Purchase Agreement between Cardium Therapeutics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd.",
"CARDIUM ANNOUNCES STRATEGIC COLLABORATION AND FUNDING WITH TAXUS PHARMACEUTICALS TO SUPPORT COMMERCIAL DEVELOPMENT OF ADVANCED REGENERATIVE THERAPEUTICS"
01/03/2014 8-K Asset disposition
Docs: "CARDIUM REPORTS ON ADVANCEMENT OF GENERX AND EXCELLAGEN BIOLOGIC PRODUCTS AND CORPORATE DEVELOPMENTS"
12/20/2013 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "CARDIUM PROVIDES UPDATE ON EXCHANGE LISTING"
11/21/2013 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Asset Acquisition Agreement between To Go Brands, Inc. and Cell-nique Corporation",
"CARDIUM'S TO GO BRANDS ACQUIRED BY CELL-NIQUE AND HEALTHY BRANDS COLLECTIVE"
10/08/2013 8-K Form 8-K - Current report
10/03/2013 8-K Form 8-K - Current report
09/17/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "CARDIUM'S LIFEAGAIN LAUNCHES FIRST LIFE INSURANCE PROGRAM DEVELOPED FOR MEN WITH ACTIVE LOCALIZED PROSTATE CANCER"
08/28/2013 8-K Form 8-K - Current report
08/16/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "CARDIUM ANNOUNCES EXCELLAGEN DISTRIBUTION AGREEMENT WITH KASIAK FOR GERMANY AND SWITZERLAND",
"CARDIUM REPORTS ON POTENTIAL USE OF EXCELLAGEN TO REPAIR PRENATALLY DIAGNOSED BIRTH DEFECTS USING MESENCHYMAL STEM CELLS",
"CARDIUM REPORTS ON SECOND QUARTER 2013 FINANCIAL RESULTS AND RECENT BUSINESS DEVELOPMENTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy